Open official notice

Enhanced Verify Evaluation Handset (CFN HH90130FA)

Official notice

7 May 2025

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Enhanced Verify Evaluation Handset (CFN HH90130FA). Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. Overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period. Published 2025-05-07.

What to do now

Stop using the affected device and follow the corrective action in the official FDA notice. Contact your healthcare provider or the manufacturer for next steps.

Units affected

534

Recall number

Z-1704-2025

Official notice

2025-05-07

The hazard

Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. Overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Other

UDI-DI 00763000930042

Event Ids

96688

Recall Numbers

Z-1704-2025

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Enhanced Verify Evaluation Handset (CFN HH90130FA)

Units affected

534

Hazard

Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. Overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Medtronic Neuromodulation

Phone

Not provided

Brand: Medtronic Neuromodulation. Contact: Medtronic Neuromodulation.

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class II

Recall details

Recall number

Z-1704-2025

Event ID

96688

Units affected

534

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 7 May 2025. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button